The External Validation of Pharmacokinetic-Pharmacodynamic Model of Propofol for Target-controlled Infusion in Children

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000511

Enrollment

Registered

2012-08-29

Start date

2012-08-27

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Propofol target effect site concentration 2,3,4,5 ug/ml intravenous injection blood sampling (X4)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiology classification 1 or 2 1-12 years old under general anesthesia

Exclusion criteria

Exclusion criteria: cardiovascular, lung, kidney, endocrine disease, coagulopathy central nervous disease, mental retardation hypersensitivity history of propofol other noncompatible patients to propofol

Design outcomes

Primary

Measure	Time frame
blood concentraion	—

Secondary

Measure	Time frame
blood pressure;heart rate	—

Countries

Korea, Republic of

Contacts

Public ContactJi-Hyoun Lee

Seoul National University Hospital

Outcome results